2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Nithipatikom K et al. 2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. 2004 Cancer Res. pmid:15604240
Kraineva J et al. Kinetics of lamellar-to-cubic and intercubic phase transitions of pure and cytochrome c containing monoolein dispersions monitored by time-resolved small-angle X-ray diffraction. 2005 Langmuir pmid:15807602
Shah MH and Paradkar A Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme. 2005 Int J Pharm pmid:15814241
Bilewicz R et al. Modified electrodes based on lipidic cubic phases. 2005 Bioelectrochemistry pmid:15833697
Lopes LB et al. Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. 2005 Eur J Pharm Biopharm pmid:15848052
Johnsson M et al. Aqueous phase behavior and dispersed nanoparticles of diglycerol monooleate/glycerol dioleate mixtures. 2005 Langmuir pmid:15896065
Amar-Yuli I and Garti N Transitions induced by solubilized fat into reverse hexagonal mesophases. 2005 Colloids Surf B Biointerfaces pmid:15921902
Masum SM et al. Effect of positively charged short peptides on stability of cubic phases of monoolein/dioleoylphosphatidic acid mixtures. 2005 Langmuir pmid:15924452
Wang Z et al. Effect of sucrose on the structure of a cubic phase formed from a monoolein/water mixture. 2005 J Colloid Interface Sci pmid:15927636
Bender J et al. Lipid cubic phases for improved topical drug delivery in photodynamic therapy. 2005 J Control Release pmid:15967535
Steluti R et al. Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. 2005 Eur J Pharm Biopharm pmid:15996585
Wörle G et al. Transformation of vesicular into cubic nanoparticles by autoclaving of aqueous monoolein/poloxamer dispersions. 2006 Eur J Pharm Sci pmid:16157479
Bonacucina G et al. Rheological and dielectric characterization of monoolein/water mesophases in the presence of a peptide drug. 2005 J Pharm Sci pmid:16200546
Lee SJ et al. Bioadhesive drug delivery system using glyceryl monooleate for the intravesical administration of paclitaxel. 2005 Chemotherapy pmid:16224181
Borné J et al. Vesicle formation and other structures in aqueous dispersions of monoolein and sodium oleate. 2003 J Colloid Interface Sci pmid:16256485
Kraineva J et al. Incorporation of alpha-chymotrypsin into the 3D channels of bicontinuous cubic lipid mesophases. 2006 Biochim. Biophys. Acta pmid:16330264
Ilardia-Arana D et al. Biorelevant dissolution media: aggregation of amphiphiles and solubility of estradiol. 2006 J Pharm Sci pmid:16374874
Fenske DB and Cullis PR Chemical exchange between lamellar and non-lamellar lipid phases. A one- and two-dimensional 31P-NMR study. 1992 Biochim. Biophys. Acta pmid:1637844
Boyd BJ et al. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. 2006 Int J Pharm pmid:16413980
Ferreira DA et al. Cryo-TEM investigation of phase behaviour and aggregate structure in dilute dispersions of monoolein and oleic acid. 2006 Int J Pharm pmid:16439076